Subscribe to
our newsletters

Subscribe to our newsletters!

Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.

Search in Nordic Life Science Insight

-
May 28, 2019
NDA

Solve your most difficult regulatory challenge at BIO Philadelphia

The path to approval is littered with pitfalls leading to unnecessary delays getting your medicine to the people who need it the most….the patients.

Solve your most difficult regulatory challenge at BIO Philadelphia

The path to approval is littered with pitfalls leading to unnecessary delays getting your medicine to the people who need it the most….the patients.

-
NDA
-
May 28, 2019

The path to approval is littered with pitfalls leading to unnecessary delays getting your medicine to the people who need it the most….the patients.

With over 25 years experience from the Life Science industry and through her numerous interactions with both the FDA and European agencies, Dr. Laurie Smaldone Alsup is perfectly positioned to help you resolve the issues that could cost you time, money and potentially, approval.

Steps to success

Step 1: Identify your most difficult strategic regulatory question in the US or European market.

Step 2: Click on the link below and schedule a complimentary 30 minute session with Dr. Laurie Smaldone Alsup, CMO/CSO NDA Group and Advisory Board member.

Step 3: Receive valuable regulatory insights into your drug development program that will save you significant time and money.

Where: BIO International Convention in Philadelphia

When: 3 – 6 June 2019

Book a meeting: info@ndareg.com


Last updated:
June 27, 2019

NDA

NDA is a world leading drug development consultancy with a dedicated team of over 150 consultants supported by an expert network and a specialist Advisory Board. Our goal is to streamline drug development in order to accelerate patient access to important medical therapies.

Click here to read more about us!

The path to approval is littered with pitfalls leading to unnecessary delays getting your medicine to the people who need it the most….the patients.

With over 25 years experience from the Life Science industry and through her numerous interactions with both the FDA and European agencies, Dr. Laurie Smaldone Alsup is perfectly positioned to help you resolve the issues that could cost you time, money and potentially, approval.

Steps to success

Step 1: Identify your most difficult strategic regulatory question in the US or European market.

Step 2: Click on the link below and schedule a complimentary 30 minute session with Dr. Laurie Smaldone Alsup, CMO/CSO NDA Group and Advisory Board member.

Step 3: Receive valuable regulatory insights into your drug development program that will save you significant time and money.

Where: BIO International Convention in Philadelphia

When: 3 – 6 June 2019

Book a meeting: info@ndareg.com


Last updated:
June 27, 2019

NDA

NDA is a world leading drug development consultancy with a dedicated team of over 150 consultants supported by an expert network and a specialist Advisory Board. Our goal is to streamline drug development in order to accelerate patient access to important medical therapies.

Click here to read more about us!